Skip to main navigation
Skip to search
Skip to main content
Macquarie University Home
Help & FAQ
Home
Profiles
Research units
Projects
Research Outputs
Datasets
Prizes
Activities
Press/Media
Impacts
Search by expertise, name or affiliation
Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Gurney, Howard
(Primary Chief Investigator)
Chapman, Nicola
(Research Coordinator)
Butala, Radhika
(Research Coordinator)
Faculty of Medicine, Health and Human Sciences
Project
:
Other
Overview
Project Details
Acronym
KEYNOTE-641
Status
Active
Effective start/end date
8/08/19
→
5/06/24
View all
View less